In the rat, quantitatively normal spermatogenesis is maintained only when intratesticular testosterone (ITT) levels greatly exceed the peripheral T concentration. When ITT concentrations fall below a threshold, germ cells are lost at specific stages of the seminiferous cycle. Germ cells can be restored by high doses of T that binds to androgen receptors (AR) in Sertoli cells. However, the relationships between germ cell dynamics, AR-mediated molecular events, and ITT concentrations are not established. ITT levels may regulate germ cell life and death through an effect on AR localization and AR mRNA or protein levels within Sertoli cells at specific stages of the cycle. We determined AR localization and mRNA and protein expression in adult rat Sertoli cells in relation to reduced and then restored ITT concentrations in vivo. ITT levels were reduced by implanting rats with T-and estradiol (E)-filled capsules for 7-28 days and subsequently restored with large T-filled capsules. AR is normally localized within Sertoli cell nuclei at stages VII-VIII of the seminiferous epithelium. After T/E treatment, AR immunostaining in Sertoli cell nuclei became nondetectable by 14-28 days but was restored 6 h following T restoration. The loss of Sertoli cell nuclear AR localization correlated with increasing numbers of apoptotic germ cells. AR mRNA levels in isolated Sertoli cells did not change through 14 days of T/E treatment, increased significantly by Day 28, and remained elevated 24 h after T restoration. AR mRNA levels in microdissected tubules at stages II-IV, VI-VIII, and IX-XII did not decrease through 14 days of T/E treatment. In contrast, AR protein levels were reduced in seminiferous tubules by Day 14 and in testes at Day 28 post-T/E treatment but were restored within 24 h by T repletion. Therefore, the reduction of ITT concentration results in a time-dependent redistribution of AR and reduced AR protein but not AR mRNA levels in Sertoli cells. Repletion of T restored AR protein and it relocated to Sertoli cell nuclei. By an unknown mechanism, T regulates AR localization within Sertoli cells to determine germ cell life or death.
INTRODUCTION
Although it is well established that testosterone (T) is required for spermatogenesis, the biologic mechanism(s) that underlies the androgen dependency of spermatogenesis is poorly understood. Sertoli cells are considered to be the target cells for androgen action; testosterone elicits its action through androgen receptor (AR) binding and translocation into the nucleus, where it initiates androgen-dependent gene transcription [1] [2] [3] [4] [5] [6] . In untreated rats, AR nuclear localization in Sertoli cells occurs at specific stages of the cycle of the seminiferous epithelium, with the highest level being during stages VII-VIII [2] [3] [4] [5] [6] , the so-called androgendependent stages of the cycle [7, 8] .
The intratesticular concentration of T in the rat is approximately 40-50 times higher than the physiologic T concentration in serum of 1-2 ng/ml [9] . Interestingly, quantitatively normal spermatogenesis can be maintained in the rat only when intratesticular T (ITT) levels are above 20 ng/ml, a level that is 10-fold greater than in the peripheral circulation [10] [11] [12] . When T levels within the testis fall below the threshold of 20 ng/ml, step 19 spermatids fail to be released, pachytene spermatocytes undergo apoptosis, and round spermatids are sloughed from the seminiferous epithelium [7] [8] [9] [10] [11] [12] . These events are initiated specifically at stages VII-VIII and presumably occur because of reduced androgen-dependent gene transcription mediated via the AR in Sertoli cells associated with these stages of germ cell development [2, 3, 5, 7, 8] . Germ cells that are lost as a consequence of reduced ITT can be restored to the testis by the administration of high doses of exogenous T that are sufficient to reestablish ITT levels that exceed the critical threshold of 20 ng/ml [9] [10] [11] .
The relationships among germ cell dynamics, AR-mediated molecular events, and ITT concentrations have not been established. Immunohistochemical studies have shown a dramatic loss of AR from Sertoli cell nuclei at stages VII-VIII of the seminiferous epithelium, when the concentration of T is profoundly decreased by the administration of a GnRH antagonist, Azaline B [5] , or the Leydig cell toxicant ethane dimethanesulfonate (EDS) [13] . This suggests that AR redistribution might be an important consequence of the effect of reduced ITT on germ cell apoptosis. However, the regulation of AR in Sertoli cells by T, involving transcriptional, translational, and posttranslational control mechanisms, also may play important roles. For example, T was reported to decrease the AR mRNA level in Sertoli cells on Day 20 of life [14] but to have stimulatory effects on the level of Sertoli cell AR protein [15, 16] . In studies of the effects of EDS treatment, an alkylating agent that kills Leydig cells, total testis AR mRNA and protein levels were not affected by reduced ITT, but ligand binding assays revealed lower AR protein levels in the nuclear frac-tion isolated from whole testes of EDS-treated rats [17, 18] . A testable, unifying hypothesis that might explain the relationship of ITT concentration to AR-mediated molecular events that lead to germ cell survival or death is that ITT concentration has effects on intracellular AR localization, AR mRNA, and/or AR protein levels within Sertoli cells at specific stages of the cycle. Perturbations of AR localization and/or protein expression may determine whether germ cells live or die.
The study reported herein was designed to address the previously mentioned hypothesis. We focused on the in vivo effects of changes in T concentration within the Sertoli cell microenvironment, that is, within the seminiferous tubule fluid of the testis, on AR localization, and on AR mRNA and protein levels within Sertoli cells, in relationship to germ cell death. For this reason, rats were implanted with T-and estradiol (E)-filled capsules to reduce ITT secondary to a reduction in serum LH but without a confounding effect on serum FSH levels [9, 10] . Our results show a time-dependent loss of AR nuclear localization in Sertoli cells at stages VI-VIII of the seminiferous epithelium and of germ cell apoptosis that accompany the reduction of ITT levels following the administration of contraceptive doses of T and E, with AR protein levels also decreasing. In contrast, AR mRNA levels remained unchanged. Within 24 h following the administration of exogenous T to the rats that had received T/E implants, AR protein was restored, and AR was again localized to Sertoli cell nuclei. These results suggest that, by an as-yet-unknown mechanism, T regulation of AR localization within Sertoli cells and of AR level in turn regulates germ cell life or death.
MATERIALS AND METHODS

Animals
Male Sprague-Dawley rats, 8-12 wk of age, were purchased from Charles River Laboratories (Kingston, MA). All rats were housed in a vivarium under a 14:10 light:dark cycle and provided water and rat chow ad libitum. To experimentally suppress LH-stimulated T production from Leydig cells and reduce ITT levels, rats were administered subdermal 2.5 cm T-and 0.1 cm 17␣-E-filled polydimethylsiloxane (Silastic, Dow Corning, Midland, TX) capsules for 7, 10, 14, 21, and 28 days or empty capsules as controls, according to methods previously described [19, 20] . To study the acute effects of T restoration following 28 days of T/E treatment, rats were implanted with 3 ϫ 8 cm (24 cm total) T-filled capsules for 6 and 24 h or empty capsules as controls. All protocols used herein were approved by the Johns Hopkins University Animal Care and Use Committee.
Tissue Fixation and Processing
Adult male Sprague-Dawley rats were anesthetized, and the thoracic cavity was opened to expose the heart. The left ventricle of the heart was punctured with a 25G butterfly needle attached to a Cole-Parmer Masterflex L/S Pump (Model 7519-20) via Masterflex 96410-14 tubing. The superior vena cava was severed, and the vasculature was flushed with PBS until the testes were visually devoid of blood. Subsequently, approximately 300 ml of Bouin fixative was infused at a rate of 7 ml/min to fix the testes in situ. The testes were removed, sliced in quarters, and postfixed in Bouin solution for 48 h at 4ЊC. The testes were washed in 50% ethanol, followed by 70% ethanol, and embedded in paraffin.
Androgen Receptor Immunohistochemistry
Testis tissue sections (6 m) were deparaffinized and rehydrated through a series of graded alcohols. For antigen retrieval, tissue sections were brought to a boil in 0.01 M citrate buffer (pH 6.0) and then cooled for 20 min, a process that was repeated four times in fresh buffer. Sections were then incubated in 2% H 2 O 2 in PBS for 30 min at room temperature to quench endogenous peroxidase activity and subsequently incubated in PBS containing 1% bovine serum albumin for 1 h at room temperature to block nonspecific binding. Sections were incubated in a humidified chamber with 5 g/ml anti-human androgen receptor (PG-21; Upstate, Charlottesville, VA) at 4ЊC overnight. Antibody binding was visualized using the Elite Vectastain ABC kit (Vector Laboratories, Burlingame, CA). Sections were counterstained with 1% methyl green and mounted with Permount. Negative controls had primary antibody or secondary antibody omitted. The localization of AR immunostaining was observed by light microscopy using a Nikon Eclipse E800 microscope (Nikon, Melville, NY) and a Plan Apo 20ϫ or 40ϫ objective. Images were captured utilizing a Princeton 5-MHz cooled CCD camera (Princeton Instruments, Trenton, NJ) and IPLab Spectrum Analysis Software (Scanalytics, Fairfax, VA) and converted to Adobe Photoshop Version 5.5 (Adobe Systems, San Jose, CA). For AR immunostaining studies, testes from three rats per treatment group were used, and at least four testis tissue cross sections were examined from each testis.
In Situ Localization of Apoptotic Cells
Testicular cells undergoing apoptosis were visualized by the TUNEL assay, which labels fragmented DNA with digoxigenin-deoxy-UTP using terminal deoxynucleotidyl transferase as detected by the anti-digoxigeninconjugated reporter system (Chemicon/Serologicals, Norcross, GA). Briefly, serial sections (6 m) from the same samples used for AR immunohistochemistry were deparaffinized, rehydrated through a series of graded alcohols and PBS, digested with 20 g/ml proteinase K for 15 min at room temperature, and washed with water. Endogenous peroxidase activity was quenched in 3% H 2 O 2 in PBS for 5 min, and tissue sections were incubated sequentially in a humidified chamber with equilibration buffer for 10 min at room temperature, terminal deoxynucleotidyl transferase (TdT) and digoxigenin-labeled deoxy-UTP for 1 h at 37ЊC, and anti-digoxigenin peroxidase conjugate for 30 min at room temperature. Sections were then stained with 3,3Ј-diaminobenzidine peroxidase (DAB) substrate solution for 2 min and counterstained with 1% methyl green. The presence of TUNEL-positive germ cells was observed by light microscopy with a Plan Apo 20ϫ objective as described previously for androgen receptor immunohistochemistry. The numbers of apoptotic germ cells detected by TUNEL staining were counted in tubules corresponding to specific stages of the cycle of the seminiferous epithelium. Random areas were viewed on testis tissue sections from three animals within each treatment group until a total of 50 tubules corresponding to each grouping of stages (II-IV, VII-VIII, or IX-XII) were examined.
Radioimmunoassays
Trunk blood was collected and serum was obtained to measure T in the peripheral circulation. Seminiferous tubule fluid (STF) was collected from testes by centrifugation according to the method previously described by Turner et al. [21] . All samples were stored at Ϫ80ЊC. T concentrations in serum and STF were assayed in duplicate by RIA using a testosterone antibody purchased from ICN (Costa Mesa, CA) and 3 H-T (New England Nuclear, Boston, MA) as previously described [12, 21] . The sensitivity of the assay was 10 pg/tube.
Seminiferous Tubule Microdissection
Seminiferous tubule segments were isolated from rat testes by transillumination-assisted microdissection as previously described [22] . For RNA isolation, approximately 60 cm of seminiferous tubules at stages II-IV, VI-VIII, and IX-XII were dissected from two testes (one rat, 30 cm per testis) from control rats and from rats implanted with T/E capsules for 7, 10, or 14 days. For protein analyses, approximately 15-20 cm of seminiferous tubules from the same stages were dissected from testes of control rats and rats implanted with T/E capsules for 7 or 14 days. Dihydrotestosterone (1 nM) was added to the dissection medium and to the tissue lysis buffer to stabilize the AR protein prior to Western blot analyses [23] . Testes from three different rats (n ϭ 3) were included as independent samples within each experimental group for isolation of RNA or protein.
Sertoli Cell Isolation
Sertoli cells were isolated from whole testes as described by Anway [24] , except the 10-min trypsin digestion step was omitted. Briefly, two decapsulated testes were incubated in 0.5 mg/ml collagenase in Hanks buffered salt solution (HBSS), pH 7.4, at 34ЊC with shaking for 15 min and then washed three times to eliminate the interstitial cells. To separate Sertoli and germ cells, the tubules were incubated in a mixture of enzymes, 0.1% collagenase (C2674; Sigma, St. Louis, MO), 0.2% hyaluronidase
FIG. 1. Testis weights (A)
and testosterone levels in serum (B) and seminiferous tubule fluid (C) from control and 7-, 10-, 14-, 21-, and 28-day T/E-treated rats and 28-day T/E-treated rats with testosterone (T) replacement for 6 and 24 h. Data represent the mean ϩ SEM for three rats (six testes) per group. a: Different from control, P Յ 0.05; b: different from 28-day T/E treated, P Յ 0.05.
(H6254; Sigma), 0.04% DNase I (D5024; Sigma), and 0.03% trypsin inhibitor (T6522; Sigma) in HBSS, pH 7.4, at 34ЊC with shaking for 40 min. The enriched Sertoli cell fraction was sedimented by centrifugation and washed in HBSS three times. The Sertoli cells were resuspended in HBSS and diluted with 2.5 volumes of 1:10 dilution of HBSS to further eliminate germ cells from Sertoli cells by hypotonic shock. The Sertoli cells were collected by centrifugation, resuspended in HBSS, and filtered through 53-m nylon mesh. The purified Sertoli cells were washed and finally resuspended in F12/DMEM (1:1) medium. Sertoli cells were counted using a hemocytometer. In each preparation, 5-7 ϫ 10 6 Sertoli cells were isolated from each testis. A typical preparation consisted of 75%-80% Sertoli cells as determined by nuclear morphology evaluated microscopically following fixation of the cells in 5% glutaraldehyde/1% osmium tetroxide in 0.1 M cacodylate buffer, embedment in Epon, and staining with 1% toluidine blue/1% sodium borate. Contaminating cells in the preparation consisted of germ (ϳ10%) and peritubular myoid (ϳ10%) cells. Preparations consistently contained Ͻ2% nonviable cells as judged by trypan blue exclusion.
Germ Cell Isolation
Pachytene spermatocytes and round spermatids were isolated from the testes of 120-day-old rats by unit gravity sedimentation (Staput) according to methods previously described [25] . The purity of the pachytene spermatocyte and round spermatid fractions was estimated to be 90% for each based on morphologic characteristics of the cells as viewed by light microscopy.
Northern Blot Analysis
RNA was purified from the microdissected seminiferous tubules and freshly isolated Sertoli cells using Trizol according to the manufacturer's instructions (Invitrogen, Carlsbad, CA). Total RNA (8 g) from the microdissected seminiferous tubules was fractionated on a 1% agarose/formaldehyde gel, transferred overnight to a nylon membrane (Hybond TM-N, Amersham Biosciences, Piscataway, NJ), and cross-linked by UV irradiation (UV Stratagene 1800, Stratagene, La Jolla, CA). Complementary DNA fragments radiolabeled with (alpha-32 P) dATP using the Rad Prime DNA Labeling Kit (Invitrogen) were used as probes for specific mRNAs. The cDNA probes were specific for clusterin [26] , cathepsin L [27] , and ribosomal protein S2 (ChoB) mRNAs. ChoB was used as a control for RNA loading [28, 29] . Northern blots were hybridized overnight at 65ЊC with labeled cDNA probes in ExpressHyb solution (Clontech, Palo Alto, CA). Following hybridization, membranes were washed in 2ϫ SSC/1.0% SDS for 30 min at 65ЊC, 1ϫ SSC/0.5% SDS for 30 min at 65ЊC, and 0.1ϫ SSC/0.1% SDS for 30 min at 65ЊC. The signals were detected using a phosphor screen and Typhoon 9200 Imaging System (Amersham Biosciences).
Relative Levels of mRNA Determined by Reverse Transcription-Polymerase Chain Reaction (RT-PCR)
Total RNA (1.5 g) from microdissected seminiferous tubules and freshly isolated Sertoli cells was reverse transcribed in a 20-l reaction at 46ЊC for 60 min using 0.2 units of Superscript II (Invitrogen) and 50 ng of oligo-dT primer in first-strand synthesis buffer according to the manufacturer's specifications. PCR was performed in a reaction volume of 25 l containing 0.5 l of the RT reaction, 400 nM sense primer, and 400 nM antisense primer using the QuantiTech SYBR green PCR kit (Qiagen, Valencia, CA). Each reaction was spiked with 0.05 units of Taq polymerase (Invitrogen) to amplify cDNA products greater than 250 bp. Genespecific primers were as follows: for AR, 5Ј GGGGCAATTCGACCA-TATCT (sense) and 5Ј CCCTTTGGCGTAACCT (antisense) to amplify a 277-bp fragment corresponding to the region 1661-1938 of the AR cDNA GenBank accession number M20133 [30] ; for ABP, 5Ј CAGCAAACCC TCTTCCTCC (sense) and 5Ј TTCCATCCACCCATAGCAGCAG (antisense) to amplify a 516-bp fragment corresponding to the region 2038-2554 of the ABP cDNA GenBank accession number M19993 [31] ; and for ribosomal L19, 5Ј CTGAAGGTCAAAGGGAATGTG (sense) and 5Ј GGACAGAGTCTTGATGATCTC (antisense) to amplify a 195-bp fragment corresponding to the region 401-595 of the L19 cDNA GenBank accession number NM031103. The PCR conditions were 26 cycles at 94ЊC for 20 sec, 56ЊC for 20 sec, and 72ЊC for 45 sec, with a final extension at 72ЊC for 1 min. PCR products (10 l) were separated on a 1.5% agarose gel, and the fluorescent signal was detected using a Typhoon 9200 Imaging System and quantified using ImageQuant software (Amersham Biosciences). PCR products were cloned into p-GemT Easy Vector (Promega, Madison, WI) and sequenced to validate the cDNA insert against the GenBank database. Signal intensities were normalized to L19 expression with the ratio of 1.0 assigned to the control group, and all treatment groups are presented relative to the control.
Western Blot Analysis
Seminiferous tubule segments, testis, pachytene spermatocytes, round spermatids, spleen, kidney, or liver were homogenized in RIPA buffer (1% Triton X-100, 15 mM Hepes pH 7.5, 0.15 mM NaCl, 1% sodium deoxycholate, 0.1% SDS, 1 mM sodium orthovanadate, 10 mM EDTA, 1 nM DHT, and 0.5% protease inhibitor cocktail). Protein concentration was determined by the BCA method (Pierce, Rockford, IL). The protein samples were added to an equal volume of 2ϫ loading buffer (100 mM Tris pH 6.8, 4% SDS, 0.2% bromophenol blue, and 20% glycerol), sonicated for 30 sec, and stored at Ϫ20ЊC until analyzed. Prior to analyses, samples were reduced with 0.1% beta-mercaptoethanol, boiled for 2 min, and loaded for electrophoresis on 10% SDS-polyacrylamide gels as described [32] . Protein was transferred to Protran Nitrocellulose (Schleicher & Schuell, Keene, NH) with a Trans-Blot SD Semi Dry Electrophoretic Transfer Cell (Bio-Rad, Hercules, CA) according to the manufacturer's specifications.
AR protein was detected by Western blot analyses using anti-AR antibody (N-20, Santa Cruz Biotechnology, Santa Cruz, CA) as previously described [23] . Briefly, membranes were blocked for 30 min with 10% nonfat dry milk in PBS plus 0.2% Tween 20 (PBS ϩ T) and then incu- bated overnight at room temperature in 1% nonfat milk in PBS ϩ T and anti-AR antibody (1:500). The next day, the membranes were washed in PBS ϩ T and incubated in a secondary anti-rabbit HRP-linked IgG (1: 3000) in PBS ϩ T for 1 h at room temperature. The chemiluminescent signal was detected on film using the SuperSignal WestPico Chemiluminescent kit (Pierce) according to the manufacturer's specifications. Membranes were then stripped using Restore Western Blot Stripping Solution (Pierce) according to the manufacturer's instructions. Membranes were reblocked for 1 h in 5% nonfat dry milk in TBSS (25 mM Tris, 137 mM NaCl, 3 mM KCl) and 0.1% Tween 20 (blocking solution) at room temperature, followed by anti-beta actin antibody (1:1000, A5441; Sigma) and/or anti-tyrosine tubulin (1:1000, T9028; Sigma) for 3 h in blocking solution followed by anti-mouse HRP-linked IgG (1:3000) for 1 h at room temperature. The chemiluminescent signal for each protein was detected as described previously. All films were scanned and intensities quantified by MacBAS software version 2.2 (Fuji Photo Film, Edison, NJ). Signal intensities were normalized to Sertoli cell tyrosine tubulin expression with a ratio of 1.0 assigned to the control groups and the treatment groups represented relative to the control. Equivalent amounts of total protein in samples were verified by detection of actin expression.
Statistical Analysis
Data are expressed as the mean ϩ SEM for three to five animals per group. Statistical differences involving multiple group comparisons were determined by one-way ANOVA followed by a multiple-range test according to the Scheffe F-test (P Ͻ 0.05).
RESULTS
Testis Weights and T Levels
As shown in Figure 1A , testis weights decreased significantly by 7 days of T/E administration, with further reductions seen through 28 days. These results coincide with the progressive loss of germ cells as previously reported [8, 9, 12] . As expected, testis weights did not change at 6 or 24 h of T replacement.
Serum T concentrations did not change over the course of T/E administration for 28 days (Fig. 1B) . However, as seen in Figure 1C , the concentration of T in STF was significantly reduced from 160 ng/ml in control rats to approximately 20 ng/ml within 7 days after T/E administration. At subsequent times following implantation of T/E capsules, the T concentration was further reduced, reaching approximately 9 ng/ml by 28 days. When the T/E capsules were removed and replaced with 24 cm T-filled capsules, serum T concentrations increased significantly at 6 and 24 h (Fig. 1B) , and the T concentration in the STF increased to over 30 ng/ml (Fig. 1C) .
Germ Cell Apoptosis Fragmented DNA (TUNEL)
The decrease in testis weights in response to T/E administration coincided with increased apoptosis of germ cells, as detected by the TUNEL assay (Fig. 2) . Only a few apoptotic germ cells typically were observed in testes from control ( Fig. 2A ) and 7-day T/E-treated (Fig. 2B) rats. An obvious increase in the number of apoptotic germ cells was seen in tubules at stages VI-VIII (Fig. 2C) but not other stages by 10 days of T/E treatment ( Table 1) . More apoptotic germ cells began to appear in stages II-IV and IX-XII, as well as stages VI-VIII, by 14 days of T/E treatment 
FIG. 4. RT-PCR analyses of the mRNA levels of androgen receptor (AR) and androgen binding protein (ABP) in Sertoli cells isolated from control (Con) rats and 7-, 14-, and 28-day T/E-treated rats and 28-day T/E-treated rats with T replacement for 24 h (T24). A)
Amplified products for AR, ABP, and ribosomal L19 mRNA visualized on agarose gels following incorporation of SYBR green during RT-PCR of total RNA isolated from purified Sertoli cells. Positive (ϩ; plasmid containing the respective cDNA) and negative (Ϫ; no added reverse transcriptase) controls are shown for each reaction. B) Graphical representation of the relative mRNA levels for AR (solid bar) and ABP (hashed bar) normalized to ribosomal L19 mRNA levels. The relative intensities obtained for AR and ABP mRNA levels in samples from control animals were assigned the value of 1.0, and all treatment groups were compared relative to the control. Data represent the mean ϩ SEM for three rats (two testes per sample) per group. a: Different from control, P Յ 0.05. ( Fig. 2D and Table 1) . A large number of apoptotic germ cells were observed in all tubules by 21 days of T/E treatment ( Fig. 2E and Table 1 ).
AR Immunohistochemistry
In the testes of control animals (Fig. 3, A and B) , nuclear AR immunostaining was prominent in Sertoli cells at stages VII-VIII of the cycle of the seminiferous epithelium and not at other stages and also in the nuclei of peritubular myoid and Leydig cells throughout the testis. In testes from rats treated with T/E for 7 (Fig. 3 , C and D) and 10 ( Fig.  3 , E and F) days, AR staining intensity became notably reduced in stage VII-VIII Sertoli cell nuclei. By Day 14 of T/E treatment (Fig. 3, G and H) , Sertoli cell nuclear AR immunostaining was absent and remained so through 21 (Fig. 3, I and J) and 28 days (Fig. 3, K and L) . By contrast, AR immunostaining was still visible in the nuclei of peritubular myoid and Leydig cells throughout the course of T/ E treatment (Fig. 3, A-L) . The apparent immunostaining present within the tubules of T/E-treated animals resembled that ascribed to steps 11-19 elongated spermatids, including the residual bodies, by Vornberger et al. [2] . The failure of Sertoli cells to release step 19 spermatids following T/ E treatment may account for the persistence of immunostaining within the tubules [8] . When Sertoli cells were viewed in longitudinal cross section at higher magnification (100ϫ), immunostaining was not present within the cytoplasm of Sertoli cells (data not shown). When animals treated with T/E for 28 days received 24 cm T implants to partially restore ITT levels, AR immunostaining in Sertoli cell nuclei at stages VII-VIII was restored within 6 h (Fig.  3, M and N) and increased further in intensity by 24 h (Fig.  3, O and P) . When primary or secondary antibodies were omitted, there was no staining (data not shown). Identical cell-and stage-specific nuclear AR immunostaining was observed with the PG-21 and N-20 AR antisera (data not shown).
RT-PCR Analyses of AR and ABP mRNA
We asked whether the diminished AR protein in Sertoli cell nuclei at 7 and 10 days of T/E treatment and its absence by 14 days were related to changes in the steady-state mRNA levels of AR. Additionally, because ABP plays a role in determining the bioavailability of T within the seminiferous tubules and the expression of ABP by Sertoli cells was shown in some studies to be under T regulation, we also measured ABP mRNA levels in concert with the levels of AR mRNA. Relative mRNA levels were analyzed ex vivo by RT-PCR in Sertoli cells freshly isolated from testes of control and 7-, 14-, and 28-day T/E-treated rats and 28-day T/E-treated rats in which T was replaced for 24 h. Figure 4A illustrates the amplified products for AR and ABP mRNAs and Figure 4B the relative intensities of the amplified products. AR mRNA levels remained constant through 14 days of T/E treatment but increased significantly by 28 days of T/E treatment compared to control levels (Fig. 4B) . ABP mRNA levels were unchanged throughout , and 14-(T/E 14) day T/E-treated rats. The relative mRNA levels for AR and ABP were normalized to ribosomal L19 mRNA levels. The relative intensities obtained for AR and ABP mRNA levels in samples from control animals within a given stage were assigned the value of 1.0, and all treatment groups were compared relative to the control. Data represent the mean ϩ SEM for three rats (two testes per sample) for each group. a: Different from control, P Յ 0.05. the course of the treatments. Sertoli cells isolated from rats in which ITT levels were restored for 24 h had no significant change in AR or ABP mRNA levels as compared to Sertoli cells from 28-day T/E-treated rats (Fig. 4B) . Similarly, neither AR nor ABP mRNA levels changed within 24 h when the T/E capsules were removed after 28 days and replaced with an empty capsule.
Following androgen withdrawal, the stages of the seminiferous epithelium can still be distinguished. Utilizing transillumination-assisted microscopy, we were able to collect stage-specific segments of seminiferous tubules from testes of rats treated with T/E for up to 14 days. The staging of the microdissected seminiferous tubules collected from control and 7-and 14-day T/E-treated rats was determined by morphological criteria and verified by Northern blot analyses of cathepsin L and clusterin mRNAs (Fig. 5A ) based on the knowledge that cathepsin L mRNA is expressed at high levels during stages VI-VIII and at low levels during stages IX-XII and II-IV [33] , whereas clusterin mRNA levels are high and relatively constant throughout the stages [34] . ChoB was used as a loading control for the RNA in the Northern blot analyses.
Using RNA isolated from the same stage-specific microdissected tubules shown in Figure 5A , we measured the expression of AR and ABP mRNA levels for stages II-IV (Fig. 5B) , VI-VIII (Fig. 5C) , and IX-XII (Fig. 5D ) of the seminiferous epithelium of control and 7-, 10-, and 14-day T/E-treated rats by RT-PCR. AR mRNA levels were increased significantly compared to controls in tubule segments from stages II-IV (Fig. 5B ) at 10 and 14 days of T/ E treatment but remained constant at stages VI-VIII (Fig.  5C ) and IX-XII (Fig. 5D) . ABP mRNA levels increased significantly in tubule segments from stages II-IV and VI-VIII following 14 days of T/E treatment but were unchanged in stages IX-XII (Fig. 5) .
Western Blot Analyses of AR protein
AR immunostaining in Sertoli cell nuclei at stages VII-VIII decreased in response to reduced STF T levels, but steady-state levels of AR mRNA did not decrease. Western blot analyses were used to determine the steady-state levels of AR protein in seminiferous tubules at specific stages of the cycle, similar to the mRNA levels determined by RT-PCR analyses. The specificity of the anti-AR antibody for Western blot analyses was determined using protein extracts from whole testis, pachytene spermatocytes, round spermatids, spleen, kidney, and liver (Fig. 6) . The ϳ110-kDa AR protein was detected in testis and weakly in the kidney but not in pachytene spermatocytes, round spermatids, liver, or spleen.
Western blot analyses of seminiferous tubules from stages II-IV, VI-VIII, and IX-XII, shown in Figure 7A , demonstrated that the AR protein level was significantly decreased in all stages at 7 and 14 days of T/E treatment. In Figure 7B , each treatment group is presented as the relative FIG. 6 . Western blot analyses of androgen receptor (AR) protein in testis, pachytene spermatocytes (pach), round spermatids (round), spleen, kidney, and liver. Equal amounts of protein (50 g) were loaded in each lane. Beta-actin was used as a control.
FIG. 8. Western blot analyses of androgen receptor (AR) protein expression in total testis homogenates from control (Con) and 28-day T/Etreated (T/E 28) and 28-day T/E-treated rats that received T replacement for 24 h (T24). A)
Representative images from Western blots for AR, tyrosine tubulin (T-tub,) and beta-actin. B) Graphical representation of the relative level of AR protein expression normalized to tyrosine tubulin expression. Tyrosine tubulin expression is specific to Sertoli cells in testis. The relative intensities obtained for AR protein expression in samples from control animals were assigned the value of 1.0, and the treatment groups were compared relative to the control. Beta-actin was used to verify that equivalent amounts of total protein (40 g) were loaded in each lane. Data represent the mean ϩ SEM for three rats (one testis per sample) for each group. a: Different from control, P Յ 0.05.
FIG. 7.
Western blot analyses of androgen receptor (AR) protein expression in microdissected tubules from stages II-IV, VI-VIII, and IX-XII in testes of control (Con) and 7-and 14-day T/E-treated rats. A) Representative images from Western blots for AR, tyrosine tubulin (T-tub), and betaactin. B) Graphical representation of the relative level of AR protein expression normalized to tyrosine tubulin expression. Tyrosine tubulin expression is specific to Sertoli cells in testis. The relative intensities obtained for AR protein expression in samples from control animals within a given stage was assigned the value of 1.0, and the treatment groups are compared relative to the control. Beta-actin was used to verify that equivalent amounts of total protein (25 g) were loaded in each lane. Data represent the mean ϩ SEM for three rats (two testes per sample) for each group. a: Different from control, P Յ 0.05; b: different from 7-day T/E treated, P Յ 0.05. change in AR protein level from the control level, normalized to a value of 1.0, within a given stage. Expression of tyrosine tubulin, specific for Sertoli cells within the seminferous epithelium, was used to normalize the amount of AR protein. The consistency of actin levels shows that equivalent amounts of total protein were loaded for each sample. In stages II-IV, AR protein levels decreased by 50% and 72% following T/E treatment for 7 and 14 days, respectively. A similar trend was seen in stages VI-VIII and IX-XII, in which AR protein levels decreased 20% and 38%, respectively, following T/E treatment for 7 days and by 68% and 70%, respectively, following T/E treatment for 14 days. Beyond 14 days of T/E treatment, seminiferous tubule segments of defined stages could no longer be identified by transillumination microscopy. Instead, Western blot analyses for AR were performed on protein extracts from whole testes. As shown in Figure 8 , AR protein levels in testes from rats treated for 28 days with T/E were decreased by 58% from control, an effect that was reversed within 24 h by T replacement. As with the Western blot analyses of Figure 7 , tyrosine tubulin was used to normalize the results, and actin was used as a loading control.
DISCUSSION
In the present study, we show that in vivo reduction of ITT concentration in adult rats results in the loss of Sertoli cell AR protein and in the stage-specific loss of AR nuclear localization but that steady-state levels of AR mRNA in Sertoli cells remain unchanged or increase. As observed in previous studies [2] [3] [4] [5] [6] , AR was detected in the nuclei of Sertoli, peritubular myoid, and Leydig cells. In Sertoli cells, the intensity of nuclear immunostaining in untreated rats was greatest in stages VII-VIII of the cycle, as expected from previous reports [2, 3] . AR immunolocalization in Sertoli cell nuclei was notably reduced by 7 days following the reduction of ITT levels by the subcutaneous implantation of capsules containing T and E and approached undetectable levels by 14 days. Implantation of T/E capsules does not affect serum FSH levels but inhibits LH secretion and endogenous Leydig cell testosterone biosynthesis [9, 10] . Within 7 days, T/E treatment effectively reduces ITT below the critical threshold of approximately 20 ng/ml that is necessary to maintain spermatogenesis [9] [10] [11] [12] . FSH levels are not affected, and previous studies have shown that FSH is not necessary to maintain or restore quantitative spermatogenesis in the adult rat (reviewed in Zirkin et al. [36] ).
We show herein that the increased number of apoptotic germ cells observed by TUNEL staining after 10-14 days of T/E treatment was specific to spermatocytes in seminiferous tubules at stages VII-VIII. AR immunolocalization in Sertoli cell nuclei in stage VII-VIII tubules was no longer observed once the ITT concentration fell below its critical threshold for maintenance of spermatogenesis. The correlation between loss of Sertoli cell nuclear AR localization and apoptosis of germ cells suggests a functional disruption of AR-mediated androgen action in Sertoli cells specific to stages VII-VIII of the seminiferous epithelium. We did, however, observe an unexplained compensatory increase in AR mRNA level in stage II-IV seminiferous tubules after 10 and 14 days of T/E treatment that coincided with the critical decrease in ITT concentration.
Our studies further examined the stage-specific loss of Sertoli cell nuclear AR localization and the apparent disruption of AR-mediated androgen action in Sertoli cells at the levels of AR mRNA and protein expression at various stages of the seminiferous epithelium. We used RT-PCR of RNA from isolated Sertoli cells and seminiferous tubule segments to show that despite the dramatic decrease in Sertoli cell nuclear AR immunolocalization following the diminution of ITT levels, steady-state measurements of AR mRNA in microdissected stage-specific seminiferous tubule segments and in isolated Sertoli cells were not significantly affected. If the concentration of ITT regulated AR mRNA levels, we would have expected a dramatic change in steady-state AR mRNA levels following the significant decrease in ITT concentration provoked by implantation of T/E capsules. Rather, we observed a significant increase in the relative level of AR mRNA in seminiferous tubules from stages II-IV on Days 10 and 14 following T/E treatment but no change in AR mRNA levels in tubules from stages VI-VIII or IX-XII through 14 days of T/E treatment. Similarly, we did not observe changes in AR mRNA levels of Sertoli cells isolated from whole testes during the period up to 14 days of T/E treatment, but AR mRNA levels increased by 28 days of T/E treatment in isolated Sertoli cells.
Interestingly, Shan et al. [35] previously concluded that AR protein levels in Sertoli cells were regulated primarily at the level of AR gene transcription. Their quantitative in situ hybridization assays showed that AR mRNA levels in Sertoli cells increase during stages IV-V and peak during stages VII-VIII of the seminiferous epithelium, thus correlating with the maximal immunocytochemical localization of AR protein in Sertoli cell nuclei at stages VII-VIII. However, similar to our findings, Blok et al. [17] reported that AR mRNA levels as measured by Northern blots with total testis RNA were not affected following treatment of rats with the Leydig cell toxicant EDS, which also reduces ITT levels. Taken together, we conclude that the steadystate levels of AR mRNA in Sertoli cells are not regulated by the concentration of ITT.
We subsequently used Western blots to show that the levels of AR protein were significantly decreased in microdissected stage-specific seminiferous tubule segments and in whole testis homogenates following T/E treatment. Interestingly, AR protein was detected in seminiferous tubule segments from control rats at stages II-IV, VI-VIII, and IX-XII despite the observation that AR was localized to Sertoli cell nuclei at stages VI-VIII but not in stages II-IV or IX-XII. We cannot, however, exclude the possibility that the AR protein and mRNA measured in seminiferous tubule segments from stages II-IV and IX-XII is derived from peritubular myoid cells rather than Sertoli cells. Perhaps AR protein redistributes to the Sertoli cell cytoplasm, although significant reductions in total AR protein levels were observed at 7 and 14 days of T/E treatment in tubule segments from each of the different stages of the seminiferous epithelium. This decrease in AR protein levels following reduction of the ITT concentration was also confirmed in whole testis homogenates from rats treated with T/E for 28 days from which staged tubule segments could not be microdissected by transillumination-assisted microscopy.
A critical factor in our ability to detect AR protein on Western blot analyses was the inclusion of 1 nM DHT in the buffers used to microdissect the seminiferous tubules and prepare the protein extracts [23] . In the absence of DHT during the tissue preparative phase, we were unable to detect AR protein by Western blot utilizing several different AR-specific antisera. This technical observation may explain results obtained by Blok et al. [17, 18] , who reported the complete loss of immunoassayable AR in testicular cells following administration of EDS. They were unable to detect AR protein in total testis homogenates from EDS-treated rats by immunoprecipitation or Western blot, an effect that was prevented if EDS-treated rats were immediately given implants containing T. They supposed that this was due to a structural modification of AR that prevented its detection by specific AR antisera following prolonged absence of androgen rather than a decrease in the amount of AR protein. On the basis of our work, however, we conclude that absolute levels of AR protein in testicular cells, specifically Sertoli cells, are decreased following T/ E treatment.
Of particular interest is the rapid return of AR protein levels within 24 h following replacement of T to restore the ITT concentration that follows the significant decrease in testicular AR protein levels of 28-day T/E-treated rats. Sertoli cell AR mRNA levels were increased after T/E treatment for 28 days and remained elevated 24 h following T replacement. Within 6 h of T replacement, AR nuclear localization in Sertoli cells reappeared in a subset of seminiferous tubules at specific stages. By 24 h following restoration of ITT levels in the range of 30-35 ng/ml, AR protein levels in the testis measured on Western blots matched the levels observed in control rats. The acute response to testosterone further suggests that additional paracrine factors within the testis are not required for the re-
